078160 — Medipost Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual income statement for Medipost Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	48,625	54,856	64,201	68,643	70,657
Cost of Revenue
Gross Profit	30,890	31,863	38,373	40,184	44,138
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	51,151	58,221	84,439	63,574	136,640
Operating Profit	-2,526	-3,365	-20,238	5,069	-65,983
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	307	602	6,508	4,414	-62,931
Provision for Income Taxes
Net Income After Taxes	-1,896	-966	2,106	4,951	-63,378
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,896	-683	3,069	5,840	-62,525
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,896	-683	3,069	5,840	-62,525
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-99.4	-156	223	-543	-1,501
Dividends per Share